|
1
|
Wang H and Ma S: The cytokine storm and
factors determining the sequence and severity of organ dysfunction
in multiple organ dysfunction syndrome. Am J Emerg Med. 26:711–715.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dewar DC and Balogh ZJ: The epidemiology
of multiple-organ failure: a definition controversy. Acta
Anaesthesiol Scand. 55:248–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dinarello CA: Proinflammatory and
anti-inflammatory cytokines as mediators in the pathogenesis of
septic shock. Chest. 112:S321–S329. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen J: The immunopathogenesis of sepsis.
Nature. 420:885–891. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brun-Buisson C: The epidemiology of the
systemic inflammatory response. Intensive Care Med. 26(Suppl 1):
S64–S74. 2000. View Article : Google Scholar
|
|
6
|
Angus DC and Wax RS: Epidemiology of
sepsis: an update. Crit Care Med. 29:S109–S116. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hollmann MW and Durieux ME: Local
anesthetics and the inflammatory response: a new therapeutic
indication? Anesthesiology. 93:858–875. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Strohm C, Barancik T, Bruhl ML, Kilian SA
and Schaper W: Inhibition of the ER-kinase cascade by PD98059 and
UO126 counteracts ischemic preconditioning in pig myocardium. J
Cardiovasc Pharmacol. 36:218–229. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Das KC and Misra HP: Prevention of
reperfusion lung injury by lidocaine in isolated rat lung
ventilated with higher oxygen levels. J Postgrad Med. 49:17–20.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmid RA, Yamashita M, ando K, Tanaka Y,
Cooper JD and Patterson GA: Lidocaine reduces reperfusion injury
and neutrophil migration in canine lung allografts. Ann Thorac
Surg. 61:949–955. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomori H, Shiraishi M, Koga H, et al:
Protective effects of lidocaine in hepatic ischemia/reperfusion
injury in vitro. Transplant Proc. 30:3740–3742. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fuentes JM, Talamini MA, Fulton WB, Hanly
EJ, Aurora AR and De Maio A: General anesthesia delays the
inflammatory response and increases survival for mice with
endotoxic shock. Clin Vaccine Immunol. 13:281–288. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gallos G, Jones DR, Nasr SH, Emala CW and
Lee HT: Local anesthetics reduce mortality and protect against
renal and hepatic dysfunction in murine septic peritonitis.
Anesthesiology. 101:902–911. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawai T and Akira S: TLR signaling. Cell
Death Differ. 13:816–825. 2006. View Article : Google Scholar
|
|
15
|
Akira S: TLR signaling. Curr Top Microbiol
Immunol. 311:1–16. 2006.
|
|
16
|
Compton T, Kurt-Jones EA, Boehme KW, et
al: Human cytomegalovirus activates inflammatory cytokine responses
via CD14 and toll-like receptor 2. J Virol. 77:4588–4596. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanimura N, Saitoh S, Matsumoto F,
Akashi-Takamura S and Miyake K: Roles for LPS-dependent interaction
and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys
Res Commun. 368:94–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: update on
toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rittirsch D, Flierl MA and Ward PA:
Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 8:776–787.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Akira S and Hemmi H: Recognition of
pathogen-associated molecular patterns by TLR family. Immunol Lett.
85:85–95. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muzio M, Bosisio D, Polentarutti N, et al:
Differential expression and regulation of toll-like receptors (TLR)
in human leukocytes: selective expression of TLR3 in dendritic
cells. J Immunol. 164:5998–6004. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O’Neill LAJ and Bowie AG: The family of
five: TIR- domain-containing adaptors in toll-like receptor
signalling. Nat Rev Immunol. 7:353–364. 2007.
|
|
23
|
Zhang FX, Kirschning CJ, Mancinelli R, et
al: Bacterial lipopolysaccharide activates nuclear factor-kappaB
through interleukin-1 signaling mediators in cultured human dermal
endothelial cells and mononuclear phagocytes. J Biol Chem.
274:7611–7614. 1999. View Article : Google Scholar
|
|
24
|
Cario E, Rosenberg IM, Brandwein SL, Beck
PL, Reinecker HC and Podolsky DK: Lipopolysaccharide activates
distinct signaling pathways in intestinal epithelial cell lines
expressing toll-like receptors. J Immunol. 164:966–972. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Faure E, Equils O, Sieling PA, et al:
Bacterial lipopolysaccharide activates NF-kappaB through toll-like
receptor 4 (TLR-4) in cultured human dermal endothelial cells.
Differential expression of TLR-4 and TLR-2 in endothelial cells. J
Biol Chem. 275:11058–11063. 2000. View Article : Google Scholar
|
|
26
|
Underhill DM, Ozinsky A, Smith KD and
Aderem A: Toll-like receptor-2 mediates mycobacteria-induced
proinflammatory signaling in macrophages. Proc Natl Acad Sci USA.
96:14459–14463. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ozinsky A, Underhill DM, Fontenot JD, et
al: The repertoire for pattern recognition of pathogens by the
innate immune system is defined by cooperation between toll-like
receptors. Proc Natl Acad Sci USA. 97:13766–13771. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Poltorak A, He X, Smirnova I, et al:
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations
in Tlr4 gene. Science. 282:2085–2088. 1998. View Article : Google Scholar
|
|
29
|
Ahn KS, Sethi G and Aggarwal BB: Nuclear
factor-kappa B: from clone to clinic. Curr Mol Med. 7:619–637.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu YC, Yeh WC and Ohashi PS: LPS/TLR4
signal transduction pathway. Cytokine. 42:145–151. 2008. View Article : Google Scholar
|
|
31
|
Hoffmann A, Natoli G and Ghosh G:
Transcriptional regulation via the NF-kappaB signaling module.
Oncogene. 25:6706–6716. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hoffmann A, Levchenko A, Scott ML and
Baltimore D: The IkappaB-NF-kappaB signaling module: temporal
control and selective gene activation. Science. 298:1241–1245.
2002. View Article : Google Scholar
|
|
33
|
Couture LA, Piao W, Ru LW, Vogel SN and
Toshchakov VY: Targeting toll-like receptor (TLR) signaling by
toll/interleukin-1 receptor (TIR) domain-containing adapter
protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides. J
Biol Chem. 287:24641–24648. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fitzgerald KA, Palsson-McDermott EM, Bowie
AG, et al: Mal (MyD88-adapter-like) is required for toll-like
receptor-4 signal transduction. Nature. 413:78–83. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gray P, Dunne A, Brikos C, Jefferies CA,
Doyle SL and O’Neill LA: MyD88 adapter-like (Mal) is phosphorylated
by Bruton’s tyrosine kinase during TLR2 and TLR4 signal
transduction. J Biol Chem. 281:10489–10495. 2006.PubMed/NCBI
|
|
36
|
Verstak B, Nagpal K, Bottomley SP,
Golenbock DT, Hertzog PJ and Mansell A: MyD88 adapter-like
(Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and
TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem.
284:24192–24203. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brown KL, Cosseau C, Gardy JL and Hancock
RE: Complexities of targeting innate immunity to treat infection.
Trends Immunol. 28:260–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hoshino K, Takeuchi O, Kawai T, et al:
Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are
hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps
gene product. J Immunol. 162:3749–3752. 1999.PubMed/NCBI
|
|
39
|
Arbour NC, Lorenz E, Schutte BC, et al:
TLR4 mutations are associated with endotoxin hyporesponsiveness in
humans. Nat Genet. 25:187–191. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Johnson GB, Brunn GJ and Platt JL: Cutting
edge: an endogenous pathway to systemic inflammatory response
syndrome (SIRS)-like reactions through Toll-like receptor 4. J
Immunol. 172:20–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Angus DC, Linde-Zwirble WT, Lidicker J,
Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis
in the United States: analysis of incidence, outcome and associated
costs of care. Crit Care Med. 29:1303–1310. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li CY, Tsai CS, Hsu PC, Chueh SH, Wong CS
and Ho ST: Lidocaine attenuates monocyte chemoattractant protein-1
production and chemotaxis in human monocytes: possible mechanisms
for its effect on inflammation. Anesth Analg. 97:1312–1316.
2003.PubMed/NCBI
|
|
43
|
Takao Y, Mikawa K, Nishina K, Maekawa N
and Obara H: Lidocaine attenuates hyperoxic lung injury in rabbits.
Acta Anaesthesiol Scand. 40:318–325. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sinclair R, Eriksson AS, Gretzer C,
Cassuto J and Thomsen P: Inhibitory effects of amide local
anaesthetics on stimulus-induced human leukocyte metabolic
activation, LTB4 release and IL-1 secretion in vitro. Acta
Anaesthesiol Scand. 37:159–165. 1993. View Article : Google Scholar
|
